Eli Lilly and Co

LLY: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|FNLOCK|QTLOCK|!^gNRw$t

Eli Lilly: Kelonia Acquisition Latest in String of Pipeline-Building Deals

Lilly announced an agreement to acquire Kelonia Therapeutics and its in vivo CAR-T pipeline and technology for $3.25 billion upfront and potential total payments up to $7 billion. The deal is expected to close in the second half of 2026. Lilly shares were flat in early trading April 20.

Sponsor Center